← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2001Last known activity
Mar 1, 2011
Acquired by NPS Pharma → Shire → Takeda on Jan 1, 2009
Timeline
Drugs by trial phase (29 distinct, 25 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Breast Neoplasms
- Colorectal Neoplasms
- Cryptococcosis
- Fever
- Hematologic Diseases
- Hot Flashes
- Infections
- Invasive Fungal Infections
- Leukemia
- Leukemia, Lymphoid
- Lung Diseases
- Lymphoma
- Lymphoma, B-Cell
- Meningeal Carcinomatosis
- Meningitis
- Multiple Myeloma
- Mycoses
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neutropenia
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Sarcoma
- Stomach Neoplasms
- Syndrome
Recent trials (27)
- NCT01337518Lead sponsorPhase 1Mar 1, 2011
- NCT01337518Study directorPhase 1Mar 1, 2011
- NCT01186328CollaboratorPhase 1Aug 1, 2010
- NCT01295697Lead sponsorPhase 1/Phase 2Feb 1, 2010
- NCT01036113Lead sponsorPhase 2Nov 1, 2009
- NCT00973752CollaboratorPhase 2Aug 1, 2009
- NCT00931840Lead sponsorPhase 2Jun 1, 2009
- NCT00750737CollaboratorPhase 3Jun 1, 2008
- NCT00549848CollaboratorPhase 3Oct 29, 2007
- NCT00520325Lead sponsorPhase 1Jun 1, 2007
- NCT00520390Lead sponsorPhase 1May 1, 2007
- NCT00520637Lead sponsorPhase 1May 1, 2007
- NCT00466583Lead sponsorPhase 1Mar 1, 2007
- NCT01656382CollaboratorPhase 4Jan 1, 2007
- NCT00415311Lead sponsorPhase 1Dec 1, 2006
Details
- Founded
- Piscataway, NJ, US Jan 1, 1981
- Last known activity
- Mar 1, 2011